GHK-Cu for skin: promising peptide or overhyped TikTok trend?

What did @willdaviesfit actually say?

Honestly? Almost nothing. The transcript from this 17,000-view video is "to the club to the right side. Right side. Yeah. Right side. Right side. Right yeah." That is the entire verbal content. Whatever the actual skincare or GHK-Cu message was, it either lived in text overlays, visuals, or audio we do not have access to here. The hashtags, though, tell a story: #ghkcu, #eczema, #acne, #primal, #skincare. So we can reasonably infer this video is positioning GHK-Cu as a solution for inflammatory skin conditions. We are going to fact-check that implied claim, because 17,000 people watched it and at least some of them walked away thinking a peptide will fix their skin.

Does the science back up GHK-Cu for skin?

Partially, and with real caveats. GHK-Cu, a naturally occurring copper-binding tripeptide, has legitimate research behind it for skin remodeling, but the jump to "it treats eczema or acne" is shakier than TikTok makes it sound.

The foundational work comes from Loren Pickart, who identified GHK-Cu in human plasma in the 1970s and spent decades studying its role in wound healing and tissue repair. More recent work by Pickart and Margolina (2018, Cosmetics) confirmed GHK-Cu stimulates collagen and elastin synthesis and modulates inflammatory cytokines in vitro. That anti-inflammatory mechanism is what people are extrapolating to eczema and acne.

For acne specifically, a 2023 review in the Journal of Cosmetic Dermatology noted that peptides with anti-inflammatory properties show promise for reducing sebum-driven inflammation, but GHK-Cu was not isolated as a proven acne treatment in any randomized controlled trial. For eczema, which involves a more complex Th2 immune dysregulation, there is essentially no clinical trial data on GHK-Cu at all. Lab data and clinical evidence are not the same thing.

What did they get wrong, or right?

We cannot fairly credit or correct specific statements because there were no specific statements. What we can say is that the framing, "all roads lead to nature" combined with GHK-Cu hashtags for eczema and acne, implies a natural solution narrative that glosses over real complexity.

GHK-Cu is not purely "natural" in any meaningful therapeutic sense when used as a topical peptide product or injectable. The doses in commercial products are engineered, not found in a field somewhere. Copper peptide skincare does have reasonable evidence for wound healing and mild anti-aging effects in human trials, including work by Leyden et al. (2009, Journal of Cosmetic Dermatology), but that is a long way from managing atopic dermatitis.

• The "natural" framing can lead people to stop evidence-based eczema treatments like topical corticosteroids or dupilumab, which actually have Phase III trial data behind them.
• Acne and eczema are clinically distinct conditions and collapsing them into the same hashtag suggests a non-specific "inflammation bad, peptide good" logic that oversimplifies both.

What should you actually know?

GHK-Cu is a legitimate area of research. It is not snake oil. But the gap between "interesting peptide biology" and "use this for your eczema" is wide, and TikTok regularly treats that gap as if it does not exist.

If you have eczema, the current standard of care includes moisturizers, topical corticosteroids for flares, calcineurin inhibitors, and for moderate-to-severe cases, biologics like dupilumab, which has strong clinical trial support. GHK-Cu has not been tested in that context. If you have acne, retinoids, benzoyl peroxide, and azelaic acid have decades of controlled trial data. A copper peptide serum does not.

That does not mean GHK-Cu has no role in skincare. Topical copper peptides are generally well-tolerated and may support skin barrier function. Used alongside proven treatments, they are unlikely to cause harm. Used instead of proven treatments for a condition like moderate eczema, they may delay effective care. The caption says "all roads lead to nature." In dermatology, some roads lead to randomized controlled trials, and those tend to be more reliable maps.